Head-to-head · Cost-Efficiency Index
Nucific vs Robinhood Telehealth
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Nucific
Shoppers willing to get a quote at intake for compounded semaglutide or tirzepatide through OpenLoop Health's providers, since no price is listed.
Visit NucificRobinhood Telehealth
Shoppers who want GLP-1 care bundled with a long peptide menu and are willing to get their price in the eligibility check.
Visit Robinhood TelehealthThe verdict
Nucific and Robinhood Telehealth tie on the Cost-Efficiency Index at 41/100, so neither wins outright on the numbers, so choose on fit. Nucific: Shoppers willing to get a quote at intake for compounded semaglutide or tirzepatide through OpenLoop Health's providers, since no price is listed. Robinhood Telehealth: Shoppers who want GLP-1 care bundled with a long peptide menu and are willing to get their price in the eligibility check.
Worth knowing either way: CoreAge Rx is one of our partners and leads our leaderboard, where partners are listed first (Cost-Efficiency Index 94/100). See how it stacks up: CoreAge Rx vs Nucific.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Nucific | Robinhood Telehealth |
|---|---|---|
| Cost-Efficiency Index | 41/100 | 41/100 |
| Semaglutide / mo | Not disclosed | Not disclosed |
| Tirzepatide / mo | Not disclosed | Not disclosed |
| Semaglutide / yr (modeled) | — | — |
| Tirzepatide / yr (modeled) | — | — |
| Coverage | Coverage not published | Not published |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #591 | #598 |
Nucific
41/100Where the value is
- Uses OpenLoop Health, a known legitimate telehealth clinical backend, for prescribing
- Offers real compounded semaglutide and tirzepatide, not just a supplement
- Established consumer brand with existing customer base from its supplement business
The tradeoffs
- No price for the prescription GLP-1 program is published
- Same brand simultaneously sells an unrelated OTC 'GLP-1 Balance' supplement, high risk of shopper confusion
Robinhood Telehealth
41/100Where the value is
- Offers compounded semaglutide, tirzepatide and a low-dose GLP-1 microdose program, plus peptides like sermorelin, BPC-157 and NAD+
- Says a licensed U.S. physician approves every protocol and that you aren't charged if you're not approved
- One bundled monthly price covers the provider fee, the pharmacy fee and the medication, according to its terms
The tradeoffs
- No price for any specific medication is published; the only figure is a 'from $149/mo' banner covering GLP-1 and peptide programs
- Doesn't list the states it serves or name its pharmacies or medical group
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.